2008: SLE: Clinical Aspects I
Search or Browse by Day

SLE: Clinical Aspects I

Sunday, October 26, 2008
422
Differences in Risk Factor Associations between Myocardial Infarctions and Cerebrovascular Accidents in Lupus Patients
423
The Metabolic Syndrome is associated with a higher level of activity over the time in mestizo Peruvian patients with Systemic Lupus Erythematosus
424
Rate and Factors Influencing Progression and Onset of Atherosclerosis in SLE
425
Effect Of Blood Pressure Control And Renal Insufficiency On The Risk Of Arterial Thrombosis In Patients With Lupus Nephritis
426
Metabolic Syndrome And Subclinical Atherosclerosis In Chinese Patients With Systemic Lupus Erythematosus (SLE)
427
Hydroxychloroquine and Prediabetes in Rheumatoid Arthritis and Systemic Lupus Erythematosus
428
The progression of preclinical atherosclerosis in Systemic Lupus Erythematosus and the possible factors involved: a two year longitudinal study
429
Predictors of the first arterial event in patients with Systemic Lupus Erythematosus
430
Accumulation of Atherosclerotic Risk Factors and Lupus Disease Risk Factors in The First 5 Years of SLE: Results from the SLICC Inception Cohort
431
Predictors of Atherosclerotic Vascular Events (AVE) in a multinational inception cohort of SLE: a time to event analysis
432
Endothelial Dysfunction in SLE: a Rationale for the Use of Statin Therapy to Assess Reversibility
433
Factors Associated with Symptoms of Depression in Systemic Lupus Erythematosus
434
Increased Susceptibility of Cognitive Impairment in Aging SLE Patients: Neural Consequences of Disease Activity, Hypertension and Sleep Disorders
435
fMRI and Cognitive and Emotional Function In SLE
436
Neural Correlates of Verbal Learning Impairments in SLE: A Study by Functional MRI
437
A Retrospective-Cohort Study of 126 Patients with Diffuse Psychiatric/Neuropsychiatric Syndrome in Neuropsychiatric Systemic Lupus Erythematosus: Therapeutic Efficacy of Intravenous Cyclophosphamide for Long-term Prognosis in Patients with Acute Confusion
438
Diffusion Tensor Imaging (DTI) and Cognitive Functioning in Systemic Lupus Erythematosus (SLE)
439
Effect of pravastatin plus ezetimibe on carotid intimal-media thickness in patients with Systemic Lupus Erythematosus
440
Increase in Neuropsychiatric and Total Organ Damage in SLE Since 1950-1979
441
Implicit Learning, Depression, and Occupational Status in Systemic Lupus Erythematosus
442
Effect of Mycophenolate Mofetil (MMF) on Inflammatory Markers of Atherosclerosis in Systemic Lupus Erythematosus (SLE)
443
Maternal Anticardiolipin Affects Childhood Development
444
Characterization of Discriminant Neuronal Antigenic Targets in Neuropsychiatric Systemic Lupus Erythematosus using an Immunoproteomic Approach
445
Homocysteine, Antiphospholipid Antibodies And Cognitive Impairment In SLE Patients
446
The MISSILE Study: A Randomised Controlled Trial of Mycophenolate Mofetil Versus Placebo on Surrogate Markers of Atherosclerosis in Systemic Lupus Erythematosus
447
Cigarrette Smoking is Associated with Oxidative Stress and Increased Concentrations of ICAM-1 in Patients with Systemic Lupus Erythematosus
448
The Effect of Vitamin D Supplementation on the Interferon Signature in Patients with SLE
449
Prevalence and Clinical Significance of Increased Creatine-Phosphokinase (CPK) Levels in a Large Single Centre Systemic Lupus Erythematosus (SLE) Cohort
450
Influence of Vitamin D Deficiency on Disease Activity Among African Americans with Systemic Lupus Erythematosus
451
Cognitive Dysfunction (CD), Psychiatric Disorders (PD) And Anti-neuronal Antibodies In Systemic Lupus Erythematosus Patients Without Overt Neuropsychiatric Manifestations
452
Development Of CAD And Risk Factors In SLE A Cohort Control Study
453
Distinct Subtypes And Prognosis Of Myelitis In Systemic Lupus Erythematosus (SLE)
454
Could Cardiac Magnetic Resonance Imaging Have A Role In Management Of Patients With Systemic Lupus Erythematosus?
455
Progression of Atherosclerosis in Pediatric Onset Systemic Lupus Erythematosus- A Longitudinal Cohort Study
456
Endothelial Function and Associated Risk Factors in Systemic Lupus Erythemosus (SLE) and Non-SLE Women
457
Intimal Medial Thickness and Coronary Artery Calcification not Associated in SLE Subjects
458
The Impact of Education Level on Cardiovascular Risk Factors and Cardiovascular Outcomes in SLE
459
Hemolytic Anemia In A Multi-ethnic Cohort Of Lupus Patients: A Clinical And Serological Perspective
460
Short-term Outcome Of Neuropsychiatric Events In SLE Patients Upon Enrollment Into An International Inception Cohort Study
664
PiHDL is a Stronger Predictor of Atherosclerosis Than Other High-Risk Inflammatory Lipids, and is Associated with a 17- Fold Increased Risk of Subclinical Atherosclerosis in SLE
665
Atherosclerotic Vascular Events in a Multinational Inception Cohort of SLE: Description and Attribution over an 8 year Period
666
Sle, Opg, Rankl, And Cardiovascular Disease
667
Systemic Lupus Erythematosus and Risk of Cardiovascular Disease. Results from the Nurses’ Health Study
668
Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients With Systemic Lupus Erythematosus
669
Carotid Intima-Media Thickness and Plaque Predict Future Cardiovascular Events in Women with Systemic Lupus Erythematosus
See more of: ACR Abstract Submission ACR Concurrent Abstract Session
<< Previous Session Level | Next Session Level >>